Development of New Strategy of Boron Neutron Capture Therapy to Cancer Combined with Tumor Specific Gene Delivery
结合肿瘤特异性基因递送的硼中子捕获治疗癌症新策略的开发
基本信息
- 批准号:11557092
- 负责人:
- 金额:$ 8.58万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We performed the study of development of enhanced effects of BNCT with tumor specific gene therapy.(1) We prepare a polyethylene-glycol (PEG) binding liposome entrapped ^<10>B compound for the delivery system. After thermal neutron irradiation of mice injected with ^<10>B-bare liposome or ^<10>B-PEG-liposome, AsPC-1 tumour growth was suppressed relative to controls. Colon 26 tumor was disappeared by BNCT with the injection of Transferrin-^<10>B-PEG-Liposome. Injection of Transferrin-^<10>B-PEG-Liposome and ^<10>B-PEG-liposome caused the greatest tumour suppression with thermal neutron irradiation in vivo.(2) We performed neutron capture autoradiography(NCAR) using CR-39 plastic track detectors. The CR-39 detectors attached with samples were exposed to thermal neutrons or cold neutrons at Rikkyo University, PSI, Institute of Jozef Stefan or Sakley Institute. We can increase the accumulation of ^<10>B atoms in the tumor tissues by PEG-liposome, which increase the retension in the blood f … More low and escape the phagocytosis by RES.(3) We developed the novel small sized palsed neutron generator. This neutron generator will be applied to BNCT.(4) It is necessary to increase the transfectional efficiency when we use non-viral vector on cancer gene therapy. We have prepared new typed plasmid DNA-cationic lipoplexes, called quatenary complex (" Qplex "), and evaluated DNA delivery efficiency. Qplex is composed with cationic liposome, pDNA, protamine and transferrin. The lipid of liposome M-( α-trimethylammonioacetyl)-didodecyl-D-glutamatechloride (TMAG) / dilauroyl-phospatidylcholine (DLPC) / dioleoylphospatidyl-ethanolamine (DOPE) (1 : 2 : 2). The transfectional efficiency of lac Z gene is increased to 52% with Qplex from 4 % with conventional cationic lipoplexes in Xgal staining. The transfection efficiency is superior in the existence of serum.(5) In order to increase the transfection efficiency in non-viral vector gene therapy, a novel fusogenic peptide, JTS-1, was evaluated in Lipoplex. Luciferase activity in cancer cell lines was greatest in the using JTS-1/LPD complex. The high transfection effeciency was observed by Xgal staining. The mean diameter of LPD is 50 nm and it is so compact compared to lipoplex ( about 600nm ). Fifty percent tumor growth suppression of AsPC-1 cells was shown at the 0.4μg per ml of tob, "a novel tumor suppressor ", DNA plasmid using JTS-1/LPD complex. The suppressive effect was caused to induction of apoptosis. Less
我们进行了肿瘤特异性基因治疗增强BNCT效应的研究。(1)我们制备了聚乙二醇(PEG)结合脂质体包埋的β-<10>B化合物作为给药系统。在注射了μ <10>B-裸脂质体或μ <10>B-PEG-脂质体的小鼠的热中子照射后,相对于对照,AsPC-1肿瘤生长受到抑制。26号结肠肿瘤经转铁蛋白-β<10>-PEG-脂质体BNCT治疗后肿瘤消失。注射转铁蛋白-β<10>-PEG-脂质体和β<10>-B-PEG-脂质体在体内引起热中子照射的最大肿瘤抑制。(2)我们使用CR-39塑料径迹探测器进行中子俘获放射自显影(NCAR)。在立教大学、PSI、约瑟夫·斯特凡研究所或萨克利研究所,将与样品相连的CR-39探测器暴露于热中子或冷中子。PEG<10>-脂质体可以增加肿瘤组织中的B原子的蓄积,从而增加肿瘤组织中的B原子在血液中的滞留, ...更多信息 降低并逃避RES的吞噬作用。(3)我们研制了一种新型的小型脉冲中子发生器。该中子发生器将应用于BNCT。(4)在肿瘤基因治疗中应用非病毒载体时,需要提高转染效率。我们制备了新型的质粒DNA-阳离子脂质复合物,称为四元复合物(“Qplex“),并评估了DNA递送效率。Qplex由阳离子脂质体、pDNA、鱼精蛋白和转铁蛋白组成。脂质体M-(α-三甲基氨乙酰基)-双十二烷基-D-脱乙酰基甜菜碱(TMAG)/二月桂酰磷脂酰胆碱(DLPC)/二油酰磷脂酰乙醇胺(DOPE)(1:2:2)。Xgal染色结果表明,Qplex可使lac Z基因的转染效率从常规阳离子脂质体的4%提高到52%。在血清存在下转染效率上级。(5)为了提高非病毒载体基因治疗的转染效率,在Lipoplex中评价了一种新的融合肽JTS-1。癌细胞系中的荧光素酶活性在使用JTS-1/LPD复合物中最大。Xgal染色显示转染效率高。LPD的平均直径为50 nm,与lipoplex(约600 nm)相比非常紧凑。用JTS-1/LPD复合物,在0.4μg/ml的tob DNA质粒作用下,AsPC-1细胞的肿瘤生长抑制率为50%。其抑制作用是通过诱导细胞凋亡而实现的。少
项目成果
期刊论文数量(130)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Yanagie, K.Ogura, K.Ono, H.Kobayashi et al.: "Application of 1OB entrapped cationic liposome to boron neutron captur therapy for pancreatic cancer model in vivo"Frontiers in Neutron Capture Therapy. 164. 1077-1083 (2001)
H.Yanagie、K.Ogura、K.Ono、H.Kobayashi 等人:“1OB 包埋阳离子脂质体在体内胰腺癌模型硼中子俘获疗法中的应用”中子俘获疗法前沿。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Yanagie, K.Ogura, K.Kono, H.Kobayashi et al.: "Accumulation of boron compounds to tumor with polyethylene-glycol binding liposome by using neutron capture autoradiography"J.Appl.Radiation and Isotopes. to be published. (2001)
H.Yanagie、K.Ogura、K.Kono、H.Kobayashi 等人:“通过使用中子捕获放射自显影技术,用聚乙二醇结合脂质体将硼化合物累积到肿瘤”J.Appl.Radiation and Isotopes。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H. Sugiyama, H. Yanagie et al.: "Identification of nuclear export signals in human type C hepatitis virus"FASEB Journal.. 13(7). 1492 (1999)
H. Sugiyama、H. Yanagie 等人:“人丙型肝炎病毒核输出信号的识别”FASEB Journal.. 13(7)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H. Yanagie, K. Ogura, H. Kobayashi et al.: "Determination of liposomal boron Biodistribution in tumor hearing mice by using neutron capture autoradiography"International Conference nuclear Energy in Central Europe 2001. 616. 2-6 (2001)
H. Yanagie、K. Ogura、H. Kobayashi 等人:“使用中子捕获放射自显影技术测定肿瘤听力小鼠中脂质体硼的生物分布”中欧核能国际会议 2001. 616. 2-6 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Ogura, A.Yamazaki, H.Yanagie et al.: "Neutron capture autoradiography for a study on boron neutron capture therapy"Radiation Measurements. 34. 555-558 (2001)
K.Ogura、A.Yamazaki、H.Yanagie 等人:“中子俘获放射自显影术用于硼中子俘获疗法的研究”辐射测量。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANAGIE Hironobu其他文献
YANAGIE Hironobu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YANAGIE Hironobu', 18)}}的其他基金
Development of Intelligent Gadorinium Neutron Capture Therapy asCancer Specific Atomic Suppression Therapy
开发智能钆中子俘获疗法作为癌症特异性原子抑制疗法
- 批准号:
23659639 - 财政年份:2011
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of Gene Therapy with Nanotechnology derived Intelligent Drug Deliver Systems
利用纳米技术衍生的智能药物输送系统开发基因治疗
- 批准号:
15390389 - 财政年份:2003
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Targeting Therapy with Intelligent Drug Delivery System using Transporter
利用转运蛋白的智能给药系统进行分子靶向治疗
- 批准号:
13557104 - 财政年份:2001
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
International Collaboration for Application of Boron Neutron Capture Therapy to Intraoperative Irradiational Therapy
硼中子俘获疗法在术中放射治疗中应用的国际合作
- 批准号:
11691202 - 财政年份:1999
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Application of Intelligent Targeting System for Cancer Gene Therapy
智能靶向系统在癌症基因治疗中的应用
- 批准号:
10470254 - 财政年份:1998
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
- 批准号:
10095606 - 财政年份:2024
- 资助金额:
$ 8.58万 - 项目类别:
Collaborative R&D
骨軟部肉腫に対するカーボン製drug delivery systemの開発
骨软组织肉瘤碳药物递送系统的开发
- 批准号:
24K12414 - 财政年份:2024
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
- 批准号:
23K16044 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Smart Nano-carrier for drug delivery system encapsulating peptide drug with high-efficiency
高效包裹肽类药物的药物递送系统智能纳米载体
- 批准号:
23K13803 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of Non-contact Nucleic Acid Drug Delivery System to Whole Body Skin - Challenge to SF Culture Tank -
开发全身皮肤非接触式核酸给药系统 - 挑战SF培养罐 -
- 批准号:
23K18592 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Pioneering research on development of "Drug Delivery System" for deworming gastrointestinal-infected Anisakis
开创性研究开发“药物输送系统”以驱除胃肠道感染的异尖线虫
- 批准号:
23K17446 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Development of an innovative drug delivery system for cancer therapy using platelets as vectors
使用血小板作为载体开发用于癌症治疗的创新药物输送系统
- 批准号:
23H02769 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Drug Delivery System for RI Drugs Using Chromophore - Assisted Light Inactivation and Computational Science
利用发色团开发 RI 药物的给药系统 - 辅助光灭活和计算科学
- 批准号:
22KJ0538 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing
局部给药系统作为糖尿病伤口愈合的抗炎和促血管生成疗法
- 批准号:
10696266 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别:
Targeted drug delivery system to overcome blood-brain barrier and therapeutic resistance to current standard of care in Glioblastoma
靶向药物输送系统可克服血脑屏障和对胶质母细胞瘤现行护理标准的治疗耐药性
- 批准号:
10659749 - 财政年份:2023
- 资助金额:
$ 8.58万 - 项目类别: